Cipla Ltd, the global pharmaceutical company and owner of Cipla Medpro, South Africa’s third largest pharmaceutical manufacturer, announced a ground-breaking market access agreement with the American Cancer Society (ACS), the Clinton Health Access Imitative (CHAI) and the pharmaceutical company Pfizer, to expand access to 16 essential cancer treatment medications, including chemotherapies, into Ethiopia, Nigeria, Kenya, Uganda, Rwanda and Tanzania.
Medpro, says that this collaboration will bring life-saving cancer treatment to these sub-Saharan African countries. “The foundation of Cipla is built on its commitment to increase accessibility of affordable and quality medicines to all citizens, so this collaboration is exactly in line with what the company stands for.”
The collaboration is part of a broader effort led by ACS and supported by CHAI to improve the market environment for cancer care in Africa.
Commenting on this partnership, Gary M Reedy, CEO of